XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-controlling Interest
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   209,684,548        
Beginning balance at Dec. 31, 2022 $ 401,682 $ 21 $ 1,972,006 $ (1,558,088) $ (11,662) $ (595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock, net of offering costs (in shares)   71,444,729        
Issuance of common stock, net of offering costs 106,057 $ 7 106,050      
Exercise of stock options (in shares)   28,663        
Exercise of stock options 46   46      
Cancellation of escrow shares in connection with Edisn acquisition (in shares)   (12,595)        
Cancellation of escrow shares in connection with Edisn acquisition (344)   (344)      
Delivery of common stock underlying restricted stock units (in shares)   454,462        
Stock-based compensation 11,738   11,738      
Molotov non-controlling interest (499)   (864)   374 (9)
Foreign currency translation adjustment 2,756         2,756
Net loss attributable to non-controlling interest (11)       (11)  
Net loss attributable to common shareholders (83,613)     (83,613)    
Ending balance at Mar. 31, 2023 $ 437,812 $ 28 2,088,632 (1,641,701) (11,299) 2,152
Ending balance (in shares) at Mar. 31, 2023   281,599,807        
Beginning balance (in shares) at Dec. 31, 2023 299,215,160 299,215,160        
Beginning balance at Dec. 31, 2023 $ 283,825 $ 30 2,136,870 (1,845,542) (11,751) 4,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 2,042 2,042        
Exercise of stock options $ 2   2      
Delivery of common stock underlying restricted stock units (in shares)   507,198        
Stock-based compensation 11,873   11,873      
Foreign currency translation adjustment (3,015)         (3,015)
Net loss attributable to non-controlling interest (574)       (574)  
Net loss attributable to common shareholders (56,010)     (56,010)    
Ending balance at Mar. 31, 2024 $ 236,101 $ 30 $ 2,148,745 $ (1,901,552) $ (12,325) $ 1,203
Ending balance (in shares) at Mar. 31, 2024 299,724,400 299,724,400